Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.
about
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicinFISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic ImplicationsWnt/β-catenin signalling in prostate cancerERG is a critical regulator of Wnt/LEF1 signaling in prostate cancerProstate cancer invasion and metastasis: insights from mining genomic data.Identification of genes regulated by Wnt/beta-catenin pathway and involved in apoptosis via microarray analysis.Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells.The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathwaysSimultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.Nuclear localizaiton of β-catenin is associated with poor survival and chemo-/radioresistance in human cervical squamous cell cancer.Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer.Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.Molecular pathology of prostate cancer.Pharmacogenomics and cancer stem cells: a changing landscape?Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.SLUG is a direct transcriptional repressor of PTEN tumor suppressor.Wnt inhibitory factor 1 (Wif1) is regulated by androgens and enhances androgen-dependent prostate development.SFRP-4 abrogates Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation.Wnt/β-catenin Signaling in Normal and Cancer Stem Cells.Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.Relationship of CK8/18 expression pattern to breast cancer immunohistochemical subtyping in Egyptian patients.Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.The complex world of oligodendroglial differentiation inhibitors.Cancer stem cell epigenetics and chemoresistance.Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-Fluorouracil and X-ray irradiation in colon cancer cells.Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer.Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells.The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells.Association between Wnt inhibitory factor 1 and receptor tyrosine kinase-like orphan receptor 2 protein expression and the clinical pathological significance in benign and malignant pancreatic lesions.PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications
P2860
Q24292953-EE8FE959-F766-425D-A757-9B549255F381Q27851411-40740659-9589-4692-A3AC-5734AD630B44Q28076060-415492D1-F127-4A07-ACDE-900DDD7DB6B7Q28269116-F83C0DBB-79C1-4BAE-AE62-174D9A3C0763Q28771736-B6ABEDF6-7F4A-4BFB-A872-1B05FC3FFA32Q30656758-91C9D259-BA00-44F1-86BF-1DEEDE6D2544Q33256754-92EA92E3-C666-4E9C-AE4C-27E6C1E113EDQ33416408-1FD52123-7B2B-40CA-82F2-5E9D38294795Q33597010-512AACE0-2060-449D-8EFC-E5EED4178FB2Q33827178-DA5EF8CE-C208-4740-BAC7-58808E640E9AQ33830798-12B5F9E6-DD01-4E38-B7BD-500AF2427058Q34029022-4042B819-9CE0-457E-ACFE-FC8423A98414Q34611577-7BCCFE51-7656-43E9-817D-2EF0F5DFCA1CQ35153370-F089B2CB-1D3B-46D0-8D15-0EBA496EE249Q35188932-7B9A9A0B-3954-47F9-BFC5-4E47970BEAB7Q36104764-A221A65B-0004-4A0C-8840-87059CC02D87Q36249264-8CDEA6EE-EC58-4480-8163-11A1337B2399Q36251549-8F0BC78B-61C6-42C0-BB85-DD3EE3FC80C5Q36272854-19EEDDD8-ECBA-45E0-AC26-99AC76AC7EC7Q36303130-A4AB4C65-BDF3-4FDB-8369-55AC4F83D2E9Q36439567-5043C5AD-650F-41DC-918A-13F31E80F86BQ36699327-97F25703-4A77-498C-B186-C708F4264220Q37132716-AE0EEA8B-ED0B-414F-A81A-DDA3D935EE1DQ37228472-B6150691-A700-42C7-ABF4-5BD34ECE47D3Q37597329-174D54CB-6DE3-45D5-82CD-8BD024027C64Q37633791-BEDA47FB-C7B9-40E6-A1D4-0387F6676D1EQ37869047-8B0E989B-FC6F-4E6D-9992-F28A65B2C4D7Q37961977-FE70F5CF-0F66-4682-8DA4-DE10DC1BF8A2Q39255564-D91F3496-B094-4E92-85BC-03B99541C104Q39400127-A4A4ACFD-B685-4AC6-B255-6CB13B57E523Q39655433-1BE21C84-0385-4FFC-8A40-0AB82B5C7B7FQ39672456-B3626835-1DC4-4029-8658-0D54C36DD36CQ39689085-E3D531A9-8666-4999-876C-0F84CE0D8D9FQ39890176-B1CBC1FD-CB43-4EED-89CA-815573EA156FQ40051402-6FF2A11D-8A04-47EC-8151-38603C802C75Q40317213-FCA0EB8F-1659-4FB3-A4EB-66F124F370E4Q42290641-6BD8B902-3A73-434D-966A-9A54AD3D375FQ45359397-F4EC390C-0F2D-4855-B511-EFB846DDC15DQ57790325-99542D24-34BD-42BD-8045-95EA917CC4ED
P2860
Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@ast
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@en
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@nl
type
label
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@ast
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@en
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@nl
prefLabel
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@ast
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@en
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@nl
P2093
P356
P1433
P1476
Inhibition of Wnt signaling do ...... mutated prostate cancer cells.
@en
P2093
P2860
P356
10.1002/PROS.20117
P577
2005-01-01T00:00:00Z